RICHARD C JR PFENNIGER
CIK 1200796 · CEO and President · last filed 2026-06-23
RICHARD C JR PFENNIGER is a CEO and President who has filed 162 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for WGS, was dated Jun 23, 2026. Across all open-market trades the lifetime net is +$421.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.67M
12
162
$421.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGS | Director | 45,082 | $81.74 | $3.69M | $0 | 1 | 2026-06-23 |
| OPK | Director | 325,000 | $1.39 | $451.7K | $256.2K | 28 | 2026-06-22 |
| FLNT | Director | 120,438 | $4.12 | $496.2K | $0 | 6 | 2026-06-18 |
| COCP | Director | 31,400 | $1.08 | $33.9K | $41.1K | 7 | 2026-01-13 |
| WGSWW | Director | 41,506 | $0.00 | $8 | $69.9K | 10 | 2025-06-23 |
| ASENSUS SURGICAL, INC. (ASXC) Delisted | Director | 0 | $0.35 | $0 | $0 | 5 | 2024-08-22 |
| GeneDx Holdings Corp. (SMFRW) Delisted | Director | — | $0.02 | — | $0 | 2 | 2022-05-06 |
| GP STRATEGIES CORP (GPX) Delisted | Director | 56,297 | $20.85 | $1.17M | $0 | 55 | 2021-10-04 |
| BioCardia, Inc. (BCDAW) Delisted | Director | 48,845 | $0.01 | $298 | $0 | 7 | 2021-01-05 |
| ASENSUS SURGICAL, INC. (TRXC) Delisted | Director | 76,232 | $4.08 | $311.0K | $54.0K | 9 | 2021-01-05 |
| BCDA | Director | 476 | $0.93 | $444 | $0 | 3 | 2018-09-26 |
| CONTINUCARE CORP (CNU) Delisted | CEO and President | 1,415,000 | — | — | $0 | 6 | 2010-09-16 |
Recent Filings
162 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | WGS | Mixed | +3,576 | $0 | EDGAR |
| 2026-06-22 | OPK | Grant (A) | — | $0 | EDGAR |
| 2026-06-18 | FLNT | Grant (A) | +30,096 | $0 | EDGAR |
| 2026-06-18 | FLNT | Grant (A) | +21,429 | $0 | EDGAR |
| 2026-01-13 | COCP | Grant (A) | — | $0 | EDGAR |
| 2025-10-30 | COCP | Grant (A) | +20,000 | $0 | EDGAR |
| 2025-06-23 | WGSWW | Mixed | +12,924 | $0 | EDGAR |
| 2025-06-23 | FLNT | Grant (A) | +39,682 | $0 | EDGAR |
| 2025-05-05 | WGSWW | Exer (M) | +918 | $0 | EDGAR |
| 2025-04-23 | OPK | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.